In a different approach, IL-7-loaded oncolytic adenovirus in conjunction with B7H3-CART cells were tested in GBM mouse models and showed improved proliferation and persistence of CAR T cells, with a three-fold increase in number of cells, as well as improved tumor control in advanced tumors compared to CAR T cell alone. This evidence concerns the gene IL7 and glioblastoma.